Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sector Update: Health Care Stocks Mixed Near Tuesday Close

02/23/2021 | 03:58pm EST


© MT Newswires 2021
All news about JOHNSON & JOHNSON
02/26HOME DEPOT, GAMESTOP, JOHNSON & JOHN : Stocks That Defined the Week
DJ
02/26Panel urges US regulators to approve single-dose Covid-19 vaccine
AQ
02/26J&J Single-Dose Covid-19 Vaccine Gains Backing From FDA Advisory Panel -- 4th..
DJ
02/26J&J Single-Dose Covid-19 Vaccine Gains Backing From FDA Advisory Panel -- 3rd..
DJ
02/26JOHNSON & JOHNSON : US expert panel endorses Johnson & Johnson's one-dose COVID-..
AQ
02/26JOHNSON & JOHNSON : Canadian regulator authorizes AstraZeneca vaccine
AQ
02/26MARKET CHATTER : Johnson & Johnson Says COVID-19 Vaccine Tied to Severe Allergic..
MT
02/26STREET COLOR : Johnson & Johnson Says it Received Preliminary Reports of Two Cas..
MT
02/26JOHNSON & JOHNSON : J&J Single-Dose Vaccine Gets Review From FDA Advisory Panel ..
DJ
02/26STREET COLOR : White House Planning Campaign to Stress Benefits on Johnson & Joh..
MT
More news
Financials (USD)
Sales 2021 91 562 M - -
Net income 2021 22 357 M - -
Net cash 2021 3 693 M - -
P/E ratio 2021 19,2x
Yield 2021 2,69%
Capitalization 417 B 417 B -
EV / Sales 2021 4,51x
EV / Sales 2022 4,24x
Nbr of Employees 134 500
Free-Float 83,4%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 180,51 $
Last Close Price 158,46 $
Spread / Highest target 26,8%
Spread / Average Target 13,9%
Spread / Lowest Target -3,45%
EPS Revisions
Managers and Directors
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON0.69%416 541
ROCHE HOLDING AG-3.87%281 904
NOVARTIS AG-5.51%197 388
ABBVIE INC.0.55%189 532
MERCK & CO., INC.-11.22%188 791
PFIZER INC.-8.12%188 042